No black box warning on record for Anastrozole

As of the latest FDA labeling reviewed, Anastrozole (ANASTROZOLE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Anastrozole medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with anastrozole use compared to tamoxifen use. Consider risks and benefits. ( 5.1 , 6.1 ) Decreases in bone mineral density may occur. Consider bone mineral density monitoring. ( 5.2 , 6.1 ) Increases in total cholesterol may occur. Consider cholesterol m

No black box warning on record for Anastrozole

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with anastrozole use compared to tamoxifen use. Consider risks and benefits. ( 5.1 , 6.1 ) Decreases in bone mineral density may occur. Consider bone mineral density monitoring. ( 5.2 , 6.1 ) Increases in total cholesterol may occur. Consider cholesterol m

Anastrozole Black Box Warning

No black box warning on record for Anastrozole

Other warnings & precautions

Anastrozole Black Box Warning

No black box warning on record for Anastrozole

Other warnings & precautions